Broadfin Capital’s AtriCure ATRC Stock Holding History

Broadfin Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-803,519	Closed	-$18M	–	75
2015 Q4	$18M	Buy	803,519 +400,000	+99%	+$8.24M	1.11%	21
2015 Q3	$8.84M	Sell	403,519 -79,835	-17%	-$2M	0.49%	53
2015 Q2	$11.9M	Sell	483,354 -50,000	-9%	-$1.12M	0.64%	41
2015 Q1	$10.9M	Sell	533,354 -292,548	-35%	-$5.67M	0.85%	33
2014 Q4	$16.5M	Sell	825,902 -100,000	-11%	-$1.72M	1.43%	20
2014 Q3	$13.6M	Sell	925,902 -59,291	-6%	-$944K	1.43%	22
2014 Q2	$18.1M	Buy	985,193 +272,698	+38%	+$4.54M	1.77%	22
2014 Q1	$13.4M	Buy	712,495 +275,000	+63%	+$5.64M	1.3%	28
2013 Q4	$8.17M	Sell	437,495 -240,048	-35%	-$3.49M	1.08%	31
2013 Q3	$7.44M	Sell	677,543 -114,298	-14%	-$1.13M	1.32%	24
2013 Q2	$7.52M	Buy	+791,841	New	+$6.9M	1.47%	24

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital's ATRC Position: Q1 2016 in Review

Broadfin Capital sold out of AtriCure (ATRC) in Q1 2016, closing a stake of 803,519 shares — an estimated $18M sold.

Broadfin Capital first reported a position in ATRC in Q2 2013 and held it in 11 quarters. The position peaked at $18.1M in Q2 2014. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.

Broadfin Capital reported no remaining AtriCure position as of Q1 2016 after selling out during the quarter.
Broadfin Capital sold 803,519 AtriCure shares in Q1 2016, an estimated $18M.
Broadfin Capital first reported a position in AtriCure in Q2 2013 and held it in 11 quarters.
Broadfin Capital's AtriCure position peaked at $18.1M in Q2 2014.
113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.

Based on Broadfin Capital's 13F filing for Q1 2016, filed 16 May 2016.